Download presentation
Presentation is loading. Please wait.
Published bySusan Hawkins Modified over 9 years ago
1
OSBI Toxicology Lab Current Technologies for Blood Testing
Robert G. Weston Forensic Toxicologist
2
We are… Seven full-time toxicologists One part-time technician
Combined 90 years of tox experience
3
What law enforcement officers do…
4
Recent DUI caseload DUI cases submitted: 2011 – 3987 cases
5
Unlike CSI, we… must separate the drugs from the blood through sample preparation. set up the analysis and wait for the data to be collected. review and interpret the data. do not know everything about every drug seen in the blood. determine the identity of substances we haven’t seen before. do not have a universal test that is effective for all drugs.
6
Everyone knows how drugs get in…
7
…but how do we get them out???
8
Composition of blood Red blood cells (40-50% of blood volume)
White blood cells (1 % of blood volume) Platelets Plasma Water (>92%) Sugars Lipids Vitamins Minerals Hormones Enzymes Antibodies Proteins
9
Volatiles analysis Blood placed into a vial Internal standard is added
Vial is heated Only volatile components evaporate into the headspace Alcohols (ethanol, methanol, isopropyl) Acetone Toluene Difluoroethane (from spray dusters)
10
Volatiles analysis A portion of the headspace gas is introduced into a
gas chromatograph Comparison is made between the sample and known standards Quantification of ethanol Identification of other volatiles
11
Enzyme-linked immunosorbent assay
ELISA Enzyme-linked immunosorbent assay
12
ELISA Presumptive for classes of compounds
Eight classes currently tested for are Barbiturates Benzodiazepines Carisoprodol/meprobamate Cocaine/benzoylecgonine Phencyclidine Phenethylamines (meth) Opiates Tetrahydrocannabinols (marijauna) Results must be confirmed by a chromatography/mass spectrometry method
13
At OSBI, all confirmatory testing in toxicology involves…
CHROMATOGRAPHY
15
The separation process
Injector Detector MP SP Column
16
The separation process
Injector Detector MP SP Column
17
The separation process
Injector Detector MP SP Column
18
The separation process
Injector Detector MP SP Column
19
The separation process
Injector Detector MP SP Column
20
The separation process
Injector Detector MP SP Column
21
The separation process
Injector Detector MP SP Column
22
The separation process
Injector Detector MP SP Column
23
The separation process
Injector Detector MP SP Column
24
The separation process
Injector Detector MP SP Column
25
The separation process
Injector Detector MP SP Column
26
The separation process
Injector Detector MP SP Column
27
The separation process
Injector Detector MP SP Column
28
The separation process
Injector Detector MP SP Column
29
The separation process
Injector Detector MP SP Column
30
The separation process
Injector Detector MP SP Column
31
The separation process
Injector Detector MP SP Column
32
The separation process
Injector Detector MP SP Column
33
The separation process
Injector Detector MP SP Column
34
The separation process
Injector Detector MP SP Column
35
The separation process
Injector Detector MP SP Column
36
The separation process
Injector Detector MP SP Column
37
The separation process
Injector Detector MP SP Column
38
The separation process
Injector Detector MP SP Column
39
The separation process
Injector Detector MP SP Column
40
The separation process
Injector Detector MP SP Column
41
The separation process
Injector Detector MP SP Column
42
The separation process
Injector Detector MP SP Column
43
The separation process
Injector Detector MP SP Column
44
The separation process
Injector Detector MP SP Column
45
The separation process
Injector Detector MP SP Column
46
The separation process
Injector Detector MP SP Column
47
The separation process
Injector Detector MP SP Column
48
The separation process
Injector Detector MP SP Column
49
The separation process
Injector Detector MP SP Column
50
The separation process
Injector Detector MP SP Column
51
The separation process
Injector Detector MP SP Column
52
The separation process
Injector Detector MP SP Column
53
The separation process
Injector Detector MP SP Column
54
The separation process
Injector Detector MP SP Column
55
The separation process
Injector Detector MP SP Column
56
The separation process
Injector Detector MP SP Column
57
The separation process
Injector Detector MP SP Column
58
The separation process
Injector Detector MP SP Column
59
The separation process
Injector Detector MP SP Column
60
The separation process
Injector Detector MP SP Column
61
The separation process
Injector Detector MP SP Column
62
Alkaline drug analysis
2 milliliters of blood +internal standards +borate buffer +n-butyl chloride +mixing +centrifuging DRUGS MOVE
63
Alkaline drug analysis
Transfer top layer to new tube Add hydrochloric acid Mix Centrifuge DRUGS MOVE
64
Alkaline drug analysis
Dispose of top layer Add sodium hydroxide Mix Add chloroform Centrifuge Transfer chloroform to vial
65
Gas chromatography mass spectrometry
66
Why negative results? Not all drugs extract well
Drug may be present in an amount less than what our methods can detect Some drugs metabolize very quickly We don’t have methods to test for every drug
67
New technology for OSBI
68
LC/MS/MS Advantages Less sample needed Less sample prep (generally)
Lower limits of detection Now capable of detecting previously unseen drugs 2.0 milliliters of blood for GC/MS testing 0.2 milliliters of blood for LC/MS/MS testing
69
Blank blood
70
New analysis capability - SPICE
Seven synthetic cannabinoids 0.5 ng/mL AM-2201 JWH-018 JWH-073 JWH-081 JWH-122 JWH-210 JWH-250 3.0 minutes!!
71
A case sample – AM-2201 found on driver and in blood
Small amounts of other “spice” compounds.
72
What else can we do? 12 benzodiazepines Under 4 minutes
Limit of detection: 5 ng/mL
73
An real case example.
74
ELISA positive for benzos, but none found
Temazepam would be found here.
75
Now we can see… temazepam oxazepam
76
Why lower limits of detection?
Fewer steps in sample prep – fewer opportunities to “lose” drugs. We can program the instrument to “see” only the drugs we are interested in. Other drugs/chemicals present do not cause a response.
77
High concentrations of other drugs
Blank Opiates Mix
78
High concentrations of other drugs
Blank THCs Mix
79
High concentrations of other drugs
Blank Spice Mix
80
LC/MS/MS limitations Limited to analyzing what we have validated
Method validation time consuming Not currently set up for unknown screening Different methods for different compounds – multiple analyses required for multiple compound types We will be able to analyze for most drugs with LC/MS/MS – it is just a matter of time
81
Upcoming projects Continue to expand capacities Quantitations Opiates
More synthetic cannabinoids “Bath salts” Cocaine Quantitations
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.